CRYSTALYNN MULLIGAN: Open Payments
NPI 1720679731 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 25 payments from 12 companies in 2025. Trend: 2023 $1,018 · 2024 $998 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $127 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| Novo Nordisk Inc | 3 | $62 |
| Baxter Healthcare | 1 | $46 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
Products named: JARDIANCE, VERQUVO, Wegovy, Hillrom - Carnation Ambulatory Monitor, FARXIGA, WAINUA, INSPIRE, SAPIEN 3 Ultra RESILIA.
Industry payments across PA — which companies pay providers there.
